Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?

References

Page 1

	Year	Citations
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Thérese Sørlie, Charles M. Perou, Robert Tibshirani, Proceedings of the National Academy of Sciences	2001	10.8K
Gene expression profiling predicts clinical outcome of breast cancer Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver, Nature Systems BiologyEngineeringBreast OncologyMedicineCancer Genomics	2002	9.5K
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer Marc J. van de Vijver, Yudong D. He, Laura van ‘t Veer, New England Journal of Medicine	2002	6.5K
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases Christine L. Carter, Carol Allen, Donald E. Henson Cancer Surgical OncologyBreast OncologyHealth SciencesSurvival RatesMedicine	1989	2.3K
Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 Marc L. Citron, Donald A. Berry, Constance Cirrincione, Journal of Clinical Oncology	2003	1.6K
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer S. Eva Singletary, Craig Allred, Pandora Ashley, Journal of Clinical Oncology	2002	1.2K
Management and survival of female breast cancer: Results of a national survey by the American college of surgeons Takuma Nemoto, J Vána, Ramez Bedwani, Cancer	1980	669
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. W. P. Peters, Maureen Ross, James J. Vredenburgh, Journal of Clinical Oncology	1993	502
Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer Martin S. Tallman, Robert P. Gray, Nicholas J. Robert, New England Journal of Medicine	2003	191
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results. Alessandro M. Gianni, Salvatore Siena, Marco Bregni, Journal of Clinical Oncology	1997	190

Page 1